Existing dietary guidelines for Crohn’s disease and ulcerative colitis

References

• Brown AC, Roy M. Does evidence exist to include dietary therapy in the treatment of Crohn’s disease? Expert Rev. Gastroenterol. Hepatol.4(2), 191–215 (2010).
   PubMed Web of Science ®Google Scholar
• Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn’s disease in adults. Am. J. Gastroenterol.104(2), 465–483 (2009).
   PubMed Web of Science ®Google Scholar
• Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am. J. Gastroenterol.105(3), 501–523 (2010).
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Fried M, Krabshuis JH et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm. Bowel Dis.16(1), 112–124 (2010).
   PubMed Web of Science ®Google Scholar
• ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J. Parenter. Enteral. Nutr.26(1 Suppl.), SA1–SA138 (2002).
   Google Scholar
• Lochs H, Dejong C, Hammarqvist F et al. ESPEN guidelines on enteral nutrition: Gastroenterology. Clin. Nutr.25, 260–274 (2006).
   PubMed Web of Science ®Google Scholar
• Van Gossum A, Cabre E, Hébuterne X et al. ESPEN Guidelines on Parenteral Nutrition: gastroenterology. Clin. Nutr.28(4), 415–427 (2009).
   PubMed Web of Science ®Google Scholar
• Working Group of the Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition; Konno M, Kobayashi A et al. Guidelines for the treatment of Crohn’s disease in children. Pediatr. Int.48(3), 349–352 (2006).
   PubMedGoogle Scholar
• Vaisman N, Dotan I, Halack A, Niv E. Malabsorption is a major contributor to underweight in Crohn’s disease patients in remission. Nutrition22(9), 855–859 (2006).
   PubMedGoogle Scholar
• Yamamoto T, Nakahigashi M, Saniabadi AR. Review article: diet and inflammatory bowel disease – epidemiology and treatment. Aliment. Pharmacol. Ther.30(2), 99–112 (2009).
   PubMed Web of Science ®Google Scholar
• Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J. Gastroenterol.15(21), 2570–2578 (2009).
   PubMed Web of Science ®Google Scholar
• Razack R, Seidner DL. Nutrition in inflammatory bowel disease. Curr. Opin. Gastroenterol.23(4), 400–405 (2007).
   PubMed Web of Science ®Google Scholar
• Song HK, Buzby GP. Nutritional support for Crohn’s disease. Surg. Clin. North Am.81(1), 103–115, viii (2001).
   PubMedGoogle Scholar
• Rigaud D, Cerf M, Angel Alberto L, Sobhani I, Carduner MJ, Mignon M. [Increase of resting energy expenditure during flare-ups in Crohn disease]. Gastroenterol. Clin. Biol.17(12), 932–937 (1993).
   PubMedGoogle Scholar
• Heyman MB, Garnett EA, Wojcicki J et al. Growth hormone treatment for growth failure in pediatric patients with Crohn’s disease. J. Pediatr.153(5), 651–658 (2008).
   PubMedGoogle Scholar
• Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP, Van Asbeck BS, Marx JJ. Iron and inflammatory bowel disease. Aliment. Pharmacol. Ther.15(4), 429–438 (2001).
   PubMed Web of Science ®Google Scholar
• Green TJ, Issenman RM, Jacobson K. Patients’ diets and preferences in a pediatric population with inflammatory bowel disease. Can. J. Gastroenterol.12(8), 544–549 (1998).
   PubMedGoogle Scholar
• Roy M. Dietary survey of Crohn’s disease patients in the state of Hawaii. University of Hawaii Thesis Project. 1–333 (2009).
   Google Scholar
• Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am. J. Clin. Nutr.65(2), 564–567 (1997).
   PubMed Web of Science ®Google Scholar
• Ballegaard M, Bjergstrøm A, Brøndum S et al. Self-reported food intolerance in chronic inflammatory bowel disease. Scand. J. Gastroenterol.32(6), 569–571 (1997).
   PubMed Web of Science ®Google Scholar
• Guilford WG. Nutritonal management of gastrointestinal tract diseases of dogs and cats. J. Nutr.124(12 Suppl.), S2663–S2669 (1994).
   Google Scholar
• de Jong NS, Leach ST, Day AS. Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation. Dig. Dis. Sci.52(9), 2029–2036 (2007).
   PubMedGoogle Scholar
• Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst. Rev.CD000542 (2007).
   PubMedGoogle Scholar
• Smith PA. Nutritional therapy for active Crohn’s disease. World J. Gastroenterol.14(27), 4420–4423 (2009).
   Google Scholar
• Dziechciarz P, Horvath A, Shamir R, Szajewska H. Meta-analysis: enteral nutrition in active Crohn’s disease in children. Aliment. Pharmacol. Ther.26(6), 795–806 (2007).
   PubMed Web of Science ®Google Scholar
• Matsui T, Sakurai T, Yao T. Nutritional therapy for Crohn’s disease in Japan. J. Gastroenterol.40(Suppl. 16), 25–31 (2005).
   PubMedGoogle Scholar
• Akobeng AK, Richmond K, Miller V et al. Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn’s disease. Clin. Nutr.26(1), 51–56 (2007).
   PubMedGoogle Scholar
• Yamamoto T, Nakahigashi M, Umegae S et al. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: a prospective, non-randomized, parallel, controlled study. Aliment. Pharmacol. Ther.25(1), 67–72 (2007).
   PubMed Web of Science ®Google Scholar
• Takagi S, Utsunomiya K, Kuriyama S et al. Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease: a randomized-controlled trial. Aliment. Pharmacol. Ther.24(9), 1333–1340 (2006).
   PubMed Web of Science ®Google Scholar
• Johnson T, Macdonald S, Hill SM et al. Treatment of active Crohn’s disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut55(3), 356–361 (2006).
   PubMed Web of Science ®Google Scholar
• Eivindson M, Grønbaek H, Nielsen JN et al. Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn’s disease treated with ω-3 or ω-6 fatty acids and corticosteroids. Scand. J. Gastroenterol.40(10), 1214–1221 (2005).
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Iida M, Kohgo Y et al. Therapeutic efficacy of infliximab on active Crohn’s disease under nutritional therapy. Scand. J. Gastroenterol.40(12), 1423–1430 (2005).
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Krantz M, Bodin L et al. Elemental versus polymeric enteral nutrition in paediatric Crohn’s disease: a multicentre randomized controlled trial. Acta Paediatr.93(3), 327–335 (2004).
   PubMedGoogle Scholar
• Bamba T, Shimoyama T, Sasaki M et al. Dietary fat attenuates the benefits of an elemental diet in active Crohn’s disease: a randomized, controlled trial. Eur. J. Gastroenterol. Hepatol.15(2), 151–157 (2003).
   PubMedGoogle Scholar
• Gassull MA, Fernández-Bañares F, Cabré E et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn’s disease: results of a double blind randomized multicentre European trial. Gut51(2), 164–168 (2002).
   PubMed Web of Science ®Google Scholar
• Sakurai T, Matsui T, Yao T et al. Short-term efficacy of enteral nutrition in the treatment of active Crohn’s disease: a randomized, controlled trial comparing nutrient formulas. JPEN J. Parenter. Enteral. Nutr.26(2), 98–103 (2002).
   PubMed Web of Science ®Google Scholar
• Verma S, Holdsworth CD, Giaffer MH. Does adjuvant nutritional support diminish steroid dependency in Crohn disease? Scand. J. Gastroenterol.36(4), 383–388 (2001).
   PubMed Web of Science ®Google Scholar
• Verma S, Kirkwood B, Brown S et al. Oral nutritional supplementation is effective in the maintenance of remission in Crohn’s disease. Dig. Liver Dis.32(9), 769–774 (2000).
   PubMedGoogle Scholar
• Fell JM, Paintin M, Arnaud-Battandier F et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease. Aliment. Pharmacol. Ther.14(3), 281–289 (2000).
   PubMed Web of Science ®Google Scholar
• Verma S, Brown S, Kirkwood B et al. Polymeric versus elemental diet as primary treatment in active Crohn’s disease: a randomized, double-blind trial. Am. J. Gastroenterol.95(3), 735–739 (2000).
   PubMed Web of Science ®Google Scholar
• Khoshoo V, Reifen R, Neuman MG et al. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn’s disease. JPEN J. Parenter. Enteral. Nutr.20(6), 401–405 (1996).
   PubMedGoogle Scholar
• Fukuda Y, Kosaka T, Okui M et al. Efficacy of nutritional therapy for active Crohn’s disease. J. Gastroenterol.30(Suppl. 8), 83–87 (1995).
   PubMedGoogle Scholar
• Breese EJ, Michie CA, Nicholls SW et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn’s disease. Aliment. Pharmacol. Ther.9(5), 547–552 (1995).
   PubMedGoogle Scholar
• Israel DM, Hassall E. Prolonged use of gastrostomy for enteral hyperalimentation in children with Crohn’s disease. Am. J. Gastroenterol.90(7), 1084–1088 (1995).
   PubMedGoogle Scholar
• Royall D, Greenberg GR, Allard JP et al. Total enteral nutrition support improves body composition of patients with active Crohn’s disease. JPEN J. Parenter. Enteral. Nutr.19(2), 95–99 (1995).
   PubMed Web of Science ®Google Scholar
• Mansfield JC, Giaffer MH, Holdsworth CD. Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn’s disease. Gut36(1), 60–66 (1995).
   PubMed Web of Science ®Google Scholar
• Ruuska T, Savilahti E, Mäki M et al. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn’s disease in children. J. Pediatr. Gastroenterol. Nutr.19(2), 175–180 (1994).
   PubMed Web of Science ®Google Scholar
• Royall D, Jeejeebhoy KN, Baker JP et al. Comparison of amino acid v peptide based enteral diets in active Crohn’s disease: clinical and nutritional outcome. Gut35(6), 783–787 (1994).
   PubMedGoogle Scholar
• González-Huix F, de León R, Fernández-Bañares F et al. Polymeric enteral diets as primary treatment of active Crohn’s disease: a prospective steroid controlled trial. Gut34(6), 778–782 (1993).
   PubMed Web of Science ®Google Scholar
• Hirakawa H, Fukuda Y, Tanida N et al. Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn’s disease. Gastroenterol. Jpn.28(3), 379–384 (1993).
   PubMedGoogle Scholar
• Rigaud D, Cosnes J, Le Quintrec Y et al. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn’s disease: elemental versus polymeric diet. Gut32(12), 1492–1497 (1991).
   PubMed Web of Science ®Google Scholar
• Demetriou AA. Comparison of enteral nutrition and drug treatment in active Crohn’s disease: results of the European Cooperative Crohn’s Disease Study IV. JPEN J. Parenter. Enteral. Nutr.16(1), 84–85 (1992).
   PubMedGoogle Scholar
• Abad-Lacruz A, González-Huix F, Esteve M et al. Liver function tests abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: a prospective randomized study of total enteral nutrition vs total parenteral nutrition. JPEN J. Parenter. Enteral. Nutr.14(6), 618–621 (1990).
   PubMed Web of Science ®Google Scholar
• Giaffer MH, North G, Holdsworth CD. Controlled trial of polymeric versus elemental diet in treatment of active Crohn’s disease. Lancet335(8693), 816–819 (1990).
   PubMed Web of Science ®Google Scholar
• Greenberg GR, Fleming CR, Jeejeebhoy KN et al. Controlled trial of bowel rest and nutritional support in the management of Crohn’s disease. Gut29(10), 1309–1315 (1998).
   Google Scholar
• Belli DC, Seidman E, Bouthillier L et al. Chronic intermittent elemental diet improves growth failure in children with Crohn’s disease. Gastroenterology94(3), 603–610 (1998).
   Google Scholar
• Akobeng AI, Clayton PE, Miller V et al. Low serum concentrations of insulin-like growth factor-I in children with active Crohn disease: effect of enteral nutritional support and glutamine supplementation. Scand. J. Gastroenterol.37(12), 1422–1427 (2002).
   PubMed Web of Science ®Google Scholar
• Akobeng AK, Miller V, Stanton J et al. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn’s disease. J. Pediatr. Gastroenterol. Nutr.30(1), 78–84 (2000).
   PubMed Web of Science ®Google Scholar
• Schneeweiss B, Lochs H, Zauner C et al. Energy and substrate metabolism in patients with active Crohn’s disease. J. Nutr.129(4), 844–848 (1999).
   PubMedGoogle Scholar
• Stolk MF, Van Erpecum KJ, Hiemstra G et al. Gallbladder motility and cholecystokinin release during long-term enteral nutrition in patients with Crohn’s disease. Scand. J. Gastroenterol.29(10), 934–939 (1994).
   PubMed Web of Science ®Google Scholar
• Lochs H, Steinhardt HJ, Klaus-Wentz B et al. Comparison of enteral nutrition and drug treatment in active Crohn’s disease. Results of the European Cooperative Crohn’s Disease Study. IV. Gastroenterology101(4), 881–888 (1991).
   PubMed Web of Science ®Google Scholar
• Axelsson C, Jarnum S. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand. J. Gastroenterol.12(1), 89–95 (1977).
   PubMed Web of Science ®Google Scholar
• Göschke H, Buess H, Gyr K et al. [Elementary diet as an alternative to parenteral feeding in severe gastrointestinal diseases]. Schweiz. Med. Wochenschr.107(2), 43–49 (1977).
   PubMedGoogle Scholar
• O’Morain C. Elemental diets in the treatment of Crohn’s disease. Proc. Nut. Soc.38, 403 (1979).
   PubMedGoogle Scholar
• Breese EJ, Michie CA, Nicholls SW et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn’s disease. Aliment. Pharmacol. Ther.9, 547–552 (1995).
   PubMedGoogle Scholar
• Fell JM, Paintin M, Arnaud-Battandier F et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease. Aliment. Pharmacol. Ther.14, 281–289 (2000).
   PubMed Web of Science ®Google Scholar
• Berni Canani R, Terrin G, Borrelli O et al. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn’s disease. Dig. Liver Dis.38, 381–387 (2006).
   PubMedGoogle Scholar
• Borrelli O, Cordischi L, Cirulli M et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized controlled open-label trial. Clin. Gastroenterol. Hepatol.4, 744–753 (2006).
   PubMed Web of Science ®Google Scholar
• Sanderson IR, Boulton P, Menzies I, Walker-Smith JA. Improvement of abnormal lactulose/rhamnose permeability in active Crohn’s disease of the small bowel by an elemental diet. Gut28(9), 1073–1076 (1987).
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of elemental diet on mucosal inflammation in patients with active Crohn’s disease: cytokine production and endoscopic and histological findings. Inflamm. Bowel Dis.11(6), 580–588 (2005).
   PubMed Web of Science ®Google Scholar
• Winitz M, Adams RF, Seedman DA, Davis PN, Jayko LG, Hamilton JA. Studies in metabolic nutrition employing chemically defined diets. II. Effects on gut microflora populations. Am. J. Clin. Nutr.23(5), 546–559 (1970).
   PubMed Web of Science ®Google Scholar
• Watanabe O, Ando T, Ishiguro K, Takahashi H et al. Enteral nutrition decreases hospitalization rate in patients with Crohn’s disease. J. Gastroenterol. Hepatol.25(1), S134–S137 (2010).
   PubMedGoogle Scholar
• Harries AD, Jones LA, Danis V et al. Controlled trial of supplemented oral nutrition in Crohn’s disease. Lancet1(8330), 887–890 (1983).
   PubMed Web of Science ®Google Scholar
• Sanderson IR, Udeen S, Davies PS, Savage MO, Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohn’s disease. Arch. Dis. Child.62(2), 123–127 (1987).
   PubMed Web of Science ®Google Scholar
• Kleinman RE, Balistreri WF, Heyman MB et al. Nutritional support for pediatric patients with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr.8(1), 8–12 (1989).
   PubMedGoogle Scholar
• Shamir R. Nutritional aspects in inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr.48(Suppl. 2), S86–S88 (2009).
   PubMedGoogle Scholar
• Yamamoto T, Nakahigashi M, Saniabadi AR et al. Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn’s disease: a prospective study. Inflamm. Bowel Dis.13(12), 1493–1501 (2007).
   PubMed Web of Science ®Google Scholar
• Makola D. Elemental and semi-elemental formulas: are they superior to polymeric formulas? Pract. Gastroenterol.24(12), 59–72 (2005).
   Google Scholar